Home Cart 0 Sign in  
X

[ CAS No. 33842-16-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 33842-16-9
Chemical Structure| 33842-16-9
Chemical Structure| 33842-16-9
Structure of 33842-16-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 33842-16-9 ]

Related Doc. of [ 33842-16-9 ]

Alternatived Products of [ 33842-16-9 ]

Product Details of [ 33842-16-9 ]

CAS No. :33842-16-9 MDL No. :MFCD01546796
Formula : C9H8O4 Boiling Point : -
Linear Structure Formula :- InChI Key :KRPFJCUXHWEVMS-UHFFFAOYSA-N
M.W : 180.16 Pubchem ID :287065
Synonyms :

Calculated chemistry of [ 33842-16-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.78
TPSA : 44.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.27 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.12
Log Po/w (XLOGP3) : 1.59
Log Po/w (WLOGP) : 1.2
Log Po/w (MLOGP) : 1.07
Log Po/w (SILICOS-IT) : 1.73
Consensus Log Po/w : 1.54

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.17
Solubility : 1.22 mg/ml ; 0.00679 mol/l
Class : Soluble
Log S (Ali) : -2.14
Solubility : 1.3 mg/ml ; 0.00723 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.23
Solubility : 1.07 mg/ml ; 0.00596 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.26

Safety of [ 33842-16-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 33842-16-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 33842-16-9 ]
  • Downstream synthetic route of [ 33842-16-9 ]

[ 33842-16-9 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 33842-16-9 ]
  • [ 1668-84-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 4, p. 871 - 887
  • 2
  • [ 33842-16-9 ]
  • [ 769-30-2 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With sodium tetrahydroborate In tetrahydrofuran at 65℃; for 0.5 h;
Stage #2: With methanol In tetrahydrofuran for 4.5 h; Reflux
6.7 g (0.037 mol) of III was dissolved in 50 ml of tetrahydrofuran, 8.6 g (0.223 mol) of sodium borohydride was added, the temperature was raised to 65 degrees Celsius, and the reaction was stirred for 30 minutes. The heating and stirring were stopped, and 8 ml of methanol was slowly added dropwise within 30 minutes. A large amount of bubbles appeared and the reaction was refluxed for 4 hours. The reaction was stopped, quenched with saturated ammonium chloride, filtered, and tetrahydrofuran was distilled off under reduced pressure. Ethyl acetate was added thereto, and the mixture was partitioned and washed with saturated brine, and dried over anhydrous sodium sulfate for 8 hours. The desiccant was removed by filtration and the solvent was evaporated under reduced pressure to give 5.6 g of white oil IV. TLC showed a single spot and was used directly in the lower reaction. The yield was close to 100percent.
Reference: [1] Patent: CN103804341, 2018, B, . Location in patent: Paragraph 0064; 0070; 0071
[2] Chemische Berichte, 1958, vol. 91, p. 36,38
  • 3
  • [ 33842-16-9 ]
  • [ 101417-40-7 ]
Reference: [1] Patent: CN103804341, 2018, B,
  • 4
  • [ 33842-16-9 ]
  • [ 5768-39-8 ]
YieldReaction ConditionsOperation in experiment
97% With potassium hydroxide In methanol; water at 20℃; for 3 h; A solution of methyl benzo[ ][1 ,3]dioxole-4-carboxylate (0.4 g, 2.22 mmol) in methanol (8.0 mL) was treated with 2.0 M aqueous KOH (2.2 mL) and the solution stirred at rt for 3 hours. The mixture was concentrated to ~3 mL volume, diluted with water (5 mL) and acidified to pH ~3 using 2.0 M HCI. The resulting precipitate was removed by filtration, washed with water then diethyl ether and dried in vacuo to give benzo[ ][1 ,3]dioxole-4-carboxylic acid as a beige solid (0.38 g, 97percent).1H NMR (400 MHz, DMSO-d6): δ = 7.28 (dd, J= 8.0, 1.2 Hz, 1H),6.97 (dd, J=8.0, 1.2 Hz, 1H),6.89 (t, J=8.0Hz, 1 H), 6.12 (s, 2H);13C NMR(100 Hz, DMSO-de) 165.5, 148.9, 148.5, 122.9, 121.6, 113.8, 112.5, 102.1.
61% at 50℃; for 5 h; Compound P-2 (500 mg, 2.8 mmol) was weighed and suspended in 5 mL of water. Add 2N NaOH aqueous solution 10mL, Heat to 50°C for about 5 hours, The reaction solution is clear. Pour the reaction solution into ice water, Adjust pH to acidic with 2N dilute HCl There is a solid precipitated, Filtering, Dry powder 280mg, Yield 61percent. Used for the next reaction without purification.
Reference: [1] Patent: WO2016/131098, 2016, A1, . Location in patent: Page/Page column 167; 168; 169
[2] Steroids, 2010, vol. 75, # 12, p. 967 - 973
[3] Journal of Agricultural and Food Chemistry, 2011, vol. 59, # 2, p. 635 - 644
[4] European Journal of Medicinal Chemistry, 2017, vol. 140, p. 604 - 614
[5] Journal of Medicinal Chemistry, 2004, vol. 47, # 4, p. 871 - 887
[6] Patent: CN104016960, 2018, B, . Location in patent: Paragraph 0084-0087; 0094-0096
[7] Patent: WO2004/4732, 2004, A1, . Location in patent: Page/Page column 66
[8] Patent: WO2004/5284, 2004, A1, . Location in patent: Page 68
  • 5
  • [ 2411-83-8 ]
  • [ 74-95-3 ]
  • [ 33842-16-9 ]
YieldReaction ConditionsOperation in experiment
81.2% With caesium carbonate In N,N-dimethyl-formamide at 110℃; for 3 h; 6.0 g (0.036 mol) of II and cesium carbonate (0.54 mol) are dissolved in 50 ml of DMF.Dibromomethane 11.5 ml (0.54 mol) was added dropwise at room temperature. After dripping, the temperature was raised to 110°C for 3 hours.The reaction was stopped after the reaction was cooled to room temperature and filtered. Add an equal volume of water and ethyl acetate to the filtrate to separate the solution.The aqueous phase is extracted twice with ethyl acetate, the organic phases are combined, washed with water, and washed with saturated brine.Anhydrous sodium sulfate was dried for 8 h. The desiccant was filtered off, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography.Elution with petroleum ether:ethyl acetate (6:1) to collect the desired components,Evaporation under reduced pressure gave a white solid of 5.2 g, yield 81.2percent.
Reference: [1] Patent: CN103804341, 2018, B, . Location in patent: Paragraph 0064; 0068; 0069
[2] Journal of Medicinal Chemistry, 2004, vol. 47, # 4, p. 871 - 887
[3] Patent: US2004/34046, 2004, A1,
[4] Patent: WO2004/4732, 2004, A1, . Location in patent: Page/Page column 65-66
[5] Patent: WO2005/34939, 2005, A1, . Location in patent: Page/Page column 76
[6] Patent: WO2004/5284, 2004, A1, . Location in patent: Page 68
  • 6
  • [ 2411-83-8 ]
  • [ 75-11-6 ]
  • [ 33842-16-9 ]
YieldReaction ConditionsOperation in experiment
52%
Stage #1: With potassium fluoride In N,N-dimethyl-formamide at 20℃; for 0.5 h;
Stage #2: at 100℃; for 5 h;
Methyl 2,3-dihydroxybenzoate (1.0 g, 5.95 mmol) in DMF (16 mL) was treated with KF (1 .79 g, 30.9 mmol) and stirred at ambient temperature for 30 minutes. Diiodomethane (1 .79 g, 6.7 mmol) was added and the reaction heated at 100 °C for 5 hours. The reaction mixture was cooled to rt, poured onto water (100 mL) and extracted using diethyl ether (2 x 50 mL). The combined organics were washed with water (50 mL), brine(50 mL), dried (MgS04) and concentrated in vacuo. The crude product was purified by column chromatography on silica gel using 10percent EtOAc-petroleum ether eluent to give methyl benzo[ ][1 ,3]dioxole-4- carboxylate as a white crystalline solid (0.56 g; 52percent);1H NMR (400 MHz, CDCI3): δ = 7.41 (dd, J= 8.0, 1.2 Hz, 1 H), 6.97 (dd, J= 8.0, 1 .2 Hz, 1 H), 6.86 (t, J = 8.0 Hz, 1 H), 6.1 (s, 2H), 3.93 (s, 3H).
37%
Stage #1: With potassium carbonate In N,N-dimethyl-formamide at 20℃;
Stage #2: at 60℃; for 6 h;
Weigh compound D-1 (1 g, 6.0 mmol) in 10 mL DMF. Add anhydrous potassium carbonate (2.5 g, 17.8 mmol), The reaction was stirred at room temperature overnight. Slowly add CH2I2 (1.9 g, 7.1 mmol) after overnight Solution with 5mL DMF, After heating, the reaction is heated to about 60°C. TLC monitors the end of the reaction, After about 6 hours, the reaction is over. Pour into ice water, Extract with ethyl acetate (50 mL × 2) The organic phase was washed three times and dried over anhydrous Na2SO4. Filtering, Concentrated as a pale yellow oil, Separation with 300-400 mesh silica gel column chromatography, The eluent was n-hexane:ethyl acetate=3:1 (v/v) to obtain 396 mg of white crystals. Yield 37percent.
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 140, p. 604 - 614
[2] Patent: WO2016/131098, 2016, A1, . Location in patent: Page/Page column 167; 168
[3] Patent: CN104016960, 2018, B, . Location in patent: Paragraph 0084-0087; 0091-0093
[4] Journal of Agricultural and Food Chemistry, 2011, vol. 59, # 2, p. 635 - 644
  • 7
  • [ 2411-83-8 ]
  • [ 75-09-2 ]
  • [ 33842-16-9 ]
Reference: [1] Steroids, 2010, vol. 75, # 12, p. 967 - 973
  • 8
  • [ 303-38-8 ]
  • [ 33842-16-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 4, p. 871 - 887
[2] Journal of Agricultural and Food Chemistry, 2011, vol. 59, # 2, p. 635 - 644
[3] Patent: WO2016/131098, 2016, A1,
[4] Patent: CN103804341, 2018, B,
[5] Patent: CN104016960, 2018, B,
  • 9
  • [ 67-56-1 ]
  • [ 5768-39-8 ]
  • [ 33842-16-9 ]
Reference: [1] Patent: WO2010/86278, 2010, A1, . Location in patent: Page/Page column 16
  • 10
  • [ 186581-53-3 ]
  • [ 5768-39-8 ]
  • [ 33842-16-9 ]
Reference: [1] Chemische Berichte, 1958, vol. 91, p. 36,38
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 33842-16-9 ]

Esters

Chemical Structure| 2150-42-7

[ 2150-42-7 ]

Methyl 2,3-dimethoxybenzoate

Similarity: 0.91

Chemical Structure| 78515-16-9

[ 78515-16-9 ]

Methyl 5-formyl-2-methoxybenzoate

Similarity: 0.87

Chemical Structure| 261767-10-6

[ 261767-10-6 ]

Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate

Similarity: 0.86

Chemical Structure| 85614-43-3

[ 85614-43-3 ]

Methyl 5-allyl-2-hydroxy-3-methoxybenzoate

Similarity: 0.86

Chemical Structure| 2150-38-1

[ 2150-38-1 ]

Methyl 3,4-dimethoxybenzoate

Similarity: 0.84

Related Parent Nucleus of
[ 33842-16-9 ]

Other Aromatic Heterocycles

Chemical Structure| 5768-39-8

[ 5768-39-8 ]

Benzo[d][1,3]dioxole-4-carboxylic acid

Similarity: 0.96

Chemical Structure| 94-53-1

[ 94-53-1 ]

Benzo[d][1,3]dioxole-5-carboxylic acid

Similarity: 0.89

Chemical Structure| 7797-83-3

[ 7797-83-3 ]

Benzo[d][1,3]dioxole-4-carbaldehyde

Similarity: 0.83

Chemical Structure| 33842-18-1

[ 33842-18-1 ]

Methyl 6-bromobenzo[d][1,3]dioxole-4-carboxylate

Similarity: 0.83

Chemical Structure| 1312610-07-3

[ 1312610-07-3 ]

Ethyl 7-bromobenzo[d][1,3]dioxole-4-carboxylate

Similarity: 0.81